BMS signs ADC development deal with Munich-based biotech worth more than $1B —BeiGene's gastric cancer drug succeeds in late-stage trial— FDA green lights Roche's Polivy in first-line DLBCL-- See more on our front page news http://bit.ly/w28kSd #bristolmyerssquibb #drugdevelopment #drugdiscovery #beigene #gastriccancer #dlbcl #clinicaltrials #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
#bristolmyerssquibb #drugdevelopment #drugdiscovery #beigene #gastriccancer #dlbcl #clinicaltrials #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma